NSE BSE
remus pharmaceuticals l stock

REMUS PHARMACEUTICALS L Share Price

- - (%)
Sector: -

16154

REMUS

img img img img
No Data Available

REMUS PHARMACEUTICALS L Share Price Update


As of the latest trading session, REMUS PHARMACEUTICALS L share price is currently at 7850, which is up by 10.00 from its previous closing. Today, the stock has fluctuated between 7850.00 and 7989.00. Over the past year, REMUS PHARMACEUTICALS L has achieved a return of 336.33 %. In the last month alone, the return has been 28.50 %.

REMUS PHARMACEUTICALS L Performance

Day Range

Low7850.00 High7989.00
7948.30

52 Week Range

Low 1711.25 High 8747.00
7948.30

Open Price

7920.00

Prev. Close

7840.00

Volume (Shares)

550.00

Total traded value

43.71

Upper Circuit

8232.00

Lower Circuit

7448.00

Note: The current prices & values are delayed, Login to your account for live updates.

REMUS PHARMACEUTICALS L Fundamentals


(Standalone)

Market Cap (Cr) 1170.80
PE Ratio (TTM) 68.66
Book Value / Share 557.11
Beta 1.06
ROE 66.10%
EPS (TTM) 114.19
Dividend Yield 0.03%
Net Profit Qtr (Cr) 0.00

REMUS PHARMACEUTICALS L Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 63.50
Operating Expense 44.67
Net Profit 16.82
Net Profit Margin (%) 26.48
Earnings Per Share (EPS) 118.72
EBITDA 23.74
Effective Tax Rate (%) 25.35
Particulars MAR 2023 (Values in Cr)
Revenue 45.03
Operating Expense 35.19
Net Profit 8.50
Net Profit Margin (%) 18.87
Earnings Per Share (EPS) 83.24
EBITDA 12.12
Effective Tax Rate (%) 25.50
Particulars MAR 2022 (Values in Cr)
Revenue 24.72
Operating Expense 20.83
Net Profit 3.43
Net Profit Margin (%) 13.87
Earnings Per Share (EPS) 34.34
EBITDA 4.85
Effective Tax Rate (%) 25.59
Particulars MAR 2023 (Values in Cr)
Book Value / Share 176.36
ROE % 66.10
ROCE % 68.21
Total Debt to Total Equity 0.32
EBITDA Margin 26.92
Particulars MAR 2022 (Values in Cr)
Book Value / Share 65.78
ROE % 70.58
ROCE % 92.25
Total Debt to Total Equity 0.05
EBITDA Margin 19.66
Particulars MAR 2021 (Values in Cr)
Book Value / Share 3143.70
ROE % 41.09
ROCE % 48.98
Total Debt to Total Equity 0.12
EBITDA Margin 8.74
Particulars MAR 2020 (Values in Cr)
Book Value / Share 2020.30
ROE % 40.10
ROCE % 45.93
Total Debt to Total Equity 0.18
EBITDA Margin 10.40
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.03
Total Assets 34.66
Total Liabilities 34.66
Total Equity 19.13
Share Outstanding 1085000
Price to Book Ratio 0.00
Return on Assets (%) 24.53
Return on Capital (%) 31.4
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.14
Total Assets 15.86
Total Liabilities 15.86
Total Equity 6.57
Share Outstanding 1000000
Price to Book Ratio 0.00
Return on Assets (%) 21.65
Return on Capital (%) 50.73
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.83
Total Assets 11.01
Total Liabilities 11.01
Total Equity 3.14
Share Outstanding 10000
Price to Book Ratio 0.00
Return on Assets (%) 9.61
Return on Capital (%) 30.96
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.19
Total Assets 5.30
Total Liabilities 5.30
Total Equity 2.02
Share Outstanding 10000
Price to Book Ratio 0.00
Return on Assets (%) 15.30
Return on Capital (%) 34.11
Particulars MAR 2023 (Values in Cr)
Net Income 11.41
Cash from Operations 8.31
Cash from Investing -15.19
Cash from Financing 11.76
Net change in Cash 1.88
Free Cash Flow 11.04
Particulars MAR 2022 (Values in Cr)
Net Income 4.61
Cash from Operations 6.23
Cash from Investing -4.54
Cash from Financing -0.17
Net change in Cash 0.31
Free Cash Flow 6.30
Particulars MAR 2021 (Values in Cr)
Net Income 1.40
Cash from Operations 0.24
Cash from Investing -0.13
Cash from Financing -0.11
Net change in Cash -0.36
Free Cash Flow 0.31
Particulars MAR 2020 (Values in Cr)
Net Income 1.09
Cash from Operations 1.60
Cash from Investing -0.55
Cash from Financing 0.06
Net change in Cash 0.80
Free Cash Flow 2.16
Company Name Price P/E P/B Market Cap 52 Week Low/High
REMUS PHARMACEUTICALS L 7840.00 53.62 13.29 1154.83 1711.25 / 8747.00
BLISS GVS PHARMA LTD 109.55 11.97 1.18 1146.89 71.00 / 148.95
CIPLA LTD 1399.35 26.53 4.23 112982.81 911.80 / 1519.00
FERMENTA BIOTECH LIMITED 161.20 0.00 1.65 474.43 132.30 / 214.00
GLAXOSMITHKLINE PHARMA LT 2291.55 56.12 21.83 38820.24 1265.00 / 2649.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
REMUS PHARMACEUTICALS L 7840.00 68.66 14.07 1154.83 1711.25 / 8747.00
AMRUTAJAN HEALTH LTD 743.50 48.85 8.20 2149.51 556.05 / 802.60
ASTRAZENECA PHARMA IND LT 5757.75 90.25 21.97 14394.38 3131.10 / 7208.00
BLISS GVS PHARMA LTD 109.55 15.13 1.16 1146.89 71.00 / 148.95
ABBOTT INDIA LIMITED 26490.20 46.86 15.21 56291.68 20594.25 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 7770.00
  • 26 Days 7237.60
  • 10 Days 7725.70
  • 50 Days 6819.20
  • 12 Days 7636.50
  • 100 Days 6703.20
  • 20 Days 7389.50
  • 200 Days 3821.00
7946.67
PIVOT
First Resistance 8093.33
Second Resistance 8346.67
Third Resistance 8493.33
First Support 7693.33
Second Support 7546.67
Third Support 7293.33
RSI 50.02
MACD 398.89
Commodity Channel Index (CCI) 75.07
ADX 36.70
Williams % R -55.46

Over 1 Month

down

28.50

Over 3 Months

down

15.30

Over 6 Months

down

49.78

Over 1 Year

down

336.33

Over 3 Years

down

0.00

Over 5 Years

down

0.00

REMUS PHARMACEUTICALS L Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

REMUS PHARMACEUTICALS L Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
26.15
Promoter Holdings
70.6
FII
3.24
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Shah Arpit Deepakkumar Shareholding of Promoter and Promoter Group 258750.0 17.57
Roma Vinodbhai Shah Shareholding of Promoter and Promoter Group 253100.0 17.18
Swapnil Jatinbhai Shah Shareholding of Promoter and Promoter Group 250000.0 16.97
Anar Swapnil Shah Shareholding of Promoter and Promoter Group 250000.0 16.97
Iegfl - Multi Opportunity Public Shareholding 41800.0 2.84
Rekha Gunavanth Kumar Public Shareholding 16000.0 1.09
Hemant Ishwarlal Modi Shareholding of Promoter and Promoter Group 14700.0 1.0
Renosen Pharmaceuticals Private Limited Shareholding of Promoter and Promoter Group 10325.0 0.7
Sonal Hemantbhai Modi Shareholding of Promoter and Promoter Group 1000.0 0.07
Mansi Aadarsh Shah Shareholding of Promoter and Promoter Group 1000.0 0.07
Vinodkumar Gandalal Shah Shareholding of Promoter and Promoter Group 750.0 0.05
Dhruvalben Vishal Shah Shareholding of Promoter and Promoter Group 375.0 0.03

REMUS PHARMACEUTICALS L

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-10-27 2.0 Interim 2023-10-28 Equity shares 2023-09-15 2.0 Final 2023-09-15 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About REMUS PHARMACEUTICALS L

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by REMUS PHARMACEUTICALS L

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Remus Pharmaceuticals Ltd?

Answer Field

The share price of Remus Pharmaceuticals Ltd for NSE is ₹ 7850 and for BSE is ₹ 0.00.

What is the Market Cap of Remus Pharmaceuticals Ltd?

Answer Field

The market cap of Remus Pharmaceuticals Ltd for NSE is ₹ 1,170.80 Cr. and for BSE is ₹ 0.0 Cr. as of now.

What is the 52 Week High and Low of Remus Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Remus Pharmaceuticals Ltd for NSE is ₹ 8747.00 and ₹ 1711.25 and for BSE is ₹ 0.00 and ₹ 0.00.

How to Buy Remus Pharmaceuticals Ltd share?

Answer Field

You can trade in Remus Pharmaceuticals Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Remus Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been 336.33%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7 Lac+ Users

icon-with-text

4.3 App Rating

icon-with-text

4 Languages

icon-with-text

₹ 3800 Cr MTF Book

icon-with-text
loader